Ulysses Management Position in Bristol (BMY) Has Trimmed by $1.83 Million as Stock Rose; Twin Securities Continues to Hold Stake in Monsanto Co New (MON)

April 26, 2018 - By Hazel Jackson

Bristol-Myers Squibb Company (NYSE:BMY) Logo

Twin Securities Inc increased its stake in Monsanto Co New (MON) by 1.95% based on its latest 2017Q4 regulatory filing with the SEC. Twin Securities Inc bought 7,615 shares as the company’s stock rose 1.12% while stock markets declined. The hedge fund held 398,895 shares of the agricultural chemicals company at the end of 2017Q4, valued at $46.58 million, up from 391,280 at the end of the previous reported quarter. Twin Securities Inc who had been investing in Monsanto Co New for a number of months, seems to be bullish on the $55.02 billion market cap company. The stock decreased 0.05% or $0.06 during the last trading session, reaching $124.68. About 2.68 million shares traded. Monsanto Company (NYSE:MON) has risen 3.06% since April 26, 2017 and is uptrending. It has underperformed by 8.49% the S&P500.

Joshua Nash decreased its stake in Bristol (BMY) by 60% based on its latest 2017Q4 regulatory filing with the SEC. Ulysses Management Llc sold 30,000 shares as the company’s stock rose 2.38% while stock markets declined. The hedge fund run by Joshua Nash held 20,000 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $1.23 million, down from 50,000 at the end of the previous reported quarter. Ulysses Management Llc who had been investing in Bristol for a number of months, seems to be less bullish one the $84.63 billion market cap company. The stock increased 0.35% or $0.18 during the last trading session, reaching $51.76. About 14.31M shares traded or 55.75% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has risen 11.37% since April 26, 2017 and is uptrending. It has underperformed by 0.18% the S&P500.

Investors sentiment decreased to 0.81 in Q4 2017. Its down 0.03, from 0.84 in 2017Q3. It turned negative, as 69 investors sold MON shares while 328 reduced holdings. 75 funds opened positions while 246 raised stakes. 317.44 million shares or 1.24% less from 321.42 million shares in 2017Q3 were reported. Soros Fund Mgmt Ltd Company has invested 0.47% in Monsanto Company (NYSE:MON). Axa holds 0.05% or 109,722 shares in its portfolio. Envestnet Asset Management owns 16,918 shares. Nichols & Pratt Advisers Limited Liability Partnership Ma holds 0.79% in Monsanto Company (NYSE:MON) or 78,179 shares. Richard Bernstein Ltd Liability Corporation holds 0.14% or 26,973 shares in its portfolio. Yakira Capital Mgmt, Connecticut-based fund reported 36,309 shares. Weitz Inv Mngmt reported 192,022 shares stake. Weatherly Asset Limited Partnership reported 8,204 shares or 0.23% of all its holdings. Fil Limited holds 0.12% of its portfolio in Monsanto Company (NYSE:MON) for 375,872 shares. Credit Suisse Ag reported 3.55 million shares stake. Captrust Advsr has 49,642 shares for 0.35% of their portfolio. Capstone Advsr Ltd Limited Liability Company has invested 0.49% in Monsanto Company (NYSE:MON). Burren Capital Advsr Limited accumulated 42.37% or 61,150 shares. Advisor Prtn has 0.15% invested in Monsanto Company (NYSE:MON). Livforsakringsbolaget Skandia Omsesidigt owns 6,639 shares.

Since January 9, 2018, it had 0 insider purchases, and 1 sale for $966,720 activity.

Among 23 analysts covering Monsanto Company (NYSE:MON), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Monsanto Company had 63 analyst reports since August 25, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, October 17 by Jefferies. The stock of Monsanto Company (NYSE:MON) earned “Equal-Weight” rating by Barclays Capital on Thursday, October 6. The rating was upgraded by Atlantic Securities to “Overweight” on Tuesday, December 1. RBC Capital Markets initiated Monsanto Company (NYSE:MON) on Thursday, February 23 with “Sector Perform” rating. BMO Capital Markets maintained it with “Buy” rating and $128.0 target in Wednesday, October 4 report. Canaccord Genuity maintained the shares of MON in report on Thursday, August 27 with “Buy” rating. The company was downgraded on Friday, August 18 by UBS. As per Thursday, September 15, the company rating was downgraded by CLSA. Goldman Sachs reinitiated Monsanto Company (NYSE:MON) rating on Wednesday, September 23. Goldman Sachs has “Neutral” rating and $105 target. On Thursday, June 29 the stock rating was maintained by Barclays Capital with “Hold”.

Investors sentiment decreased to 0.94 in Q4 2017. Its down 0.09, from 1.03 in 2017Q3. It turned negative, as 72 investors sold BMY shares while 526 reduced holdings. 106 funds opened positions while 457 raised stakes. 1.11 billion shares or 0.48% more from 1.11 billion shares in 2017Q3 were reported. Tnb Fincl stated it has 0.18% in Bristol-Myers Squibb Company (NYSE:BMY). Parthenon Ltd Liability Company holds 10,640 shares. Schroder Invest Management Group Incorporated stated it has 654,101 shares or 0.07% of all its holdings. Exxonmobil Management Tx owns 260,243 shares or 0.44% of their US portfolio. Fmr Ltd Limited Liability Company invested in 25.33M shares. Tudor Et Al reported 29,786 shares stake. M&R Mngmt stated it has 0.42% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Evercore Wealth Mgmt Limited Liability Company holds 0.27% or 116,860 shares in its portfolio. Sol Mngmt reported 0.34% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). State Board Of Administration Of Florida Retirement Sys holds 0.38% in Bristol-Myers Squibb Company (NYSE:BMY) or 2.34 million shares. Nuveen Asset Mgmt Limited Company holds 0.1% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 254,116 shares. Regentatlantic Cap Lc holds 15,709 shares. Philadelphia holds 0.12% or 24,195 shares in its portfolio. Teachers Insur And Annuity Association Of America accumulated 7,000 shares. Accredited Investors invested 0.28% in Bristol-Myers Squibb Company (NYSE:BMY).

Since December 12, 2017, it had 1 insider purchase, and 1 sale for $85,985 activity. $249,187 worth of stock was bought by Samuels Theodore R. II on Friday, December 15.

Ulysses Management Llc, which manages about $1.47 billion and $940.35M US Long portfolio, upped its stake in Spdr S&P 500 Etf Tr (Put) (SPY) by 225,000 shares to 1.83 million shares, valued at $487.02M in 2017Q4, according to the filing. It also increased its holding in Comcast Corp. Cl A (NASDAQ:CMCSA) by 567,600 shares in the quarter, for a total of 647,600 shares, and has risen its stake in Citigroup Inc (NYSE:C).

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>